BODY PURE TABLET

Manufacturer: Heel Inc
Effective date: 2012-05-29
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:03:49

Label at a glance#

ProductBody Pure

Active ingredient.ALPHA.-LIPOIC ACID, AVENA SATIVA FLOWERING TOP, RICINUS COMMUNIS SEED, SOLIDAGO VIRGAUREA FLOWERING TOP, VIOLA TRICOLOR, BERBERIS VULGARIS ROOT BARK, CAFFEINE, JUGLANS REGIA FLOWERING TOP, FRANGULA PURSHIANA BARK, URTICA URENS, CHOLESTEROL, INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED), KEROSENE, TOBACCO LEAF, ALCOHOL, X-RAY EXPOSED (1000 RAD), STRYCHNOS NUX-VOMICA SEED

Label structure8 sections

Indications and uses

For the temporary relief of: Fatigue Mild Skin Rashes Nausea and Headaches

Dosage and administration

Adults and children above 6 years: 1 tablet sublingually or dissolved completely in mouth 3 times daily of as directed by a physician. Infants and children to 6 years: 1/2 the adult dosage.

Label contents#

Full prescribing information#

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of the reach of children.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

For the temporary relief of:

Fatigue
Mild Skin Rashes
Nausea and Headaches

WARNINGS

WARNINGS SECTION

If symptoms persist or worsen, a physician should be consulted. As with any drug, if you are pregnant or nursing a baby, seek the advise of a health care professional before using this product.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Adults and children above 6 years: 1 tablet sublingually or dissolved completely in mouth 3 times daily of as directed by a physician. Infants and children to 6 years: 1/2 the adult dosage.

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Each 300mg tablet contains as active ingredients: a-Lipicum 3X, Avena saltvia 3X, Ricinus communis 3X, Solidago vigaurea 4X, Viola tricolor 4X, Berberis vulgaris 6X, Caffeinum 6X, Juglans regia 6X, Rhamus purshiana 6X, Urtica urens 6X, Cholesterium 10X, Influenzium 12X, Petroleum 12X, Tabacum 12X, X-ray 12X, Nux vomica 30x 16.67 mg

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients: Lactose, Magnesium Sterarate

PURPOSE

OTC - PURPOSE SECTION

Fatigue, Mild Skin Rashes, Nausea, and Headaches

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50114-4426-2	2019-11-13	C162847	48780-1	97449f38-d286-f6ea-e053-dbdaa90aa703	BODY PURE TABLET

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50114-4426-2	Body Pure	100 in 1 BOTTLE	TABLET	100		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50114-4426	BODY PURE (.ALPHA.-LIPOIC ACID AND AVENA SATIVA FLOWERING TOP AND RICINUS COMMUNIS SEED AND SOLIDAGO VIRGAUREA FLOWERING TOP AND VIOLA TRICOLOR AND BERBERIS VULGARIS ROOT BARK AND CAFFEINE AND JUGLANS REGIA FLOWERING TOP AND FRANGULA PURSHIANA BARK AND URTICA URENS AND CHOLESTEROL AND INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED) AND KEROSENE AND TOBACCO LEAF AND ALCOHOL, X-RAY EXPOSED (1000 RAD) AND STRYCHNOS NUX-VOMICA SEED) TABLET [HEEL INC]	1	Legacy NDC, 1 package rows	20120615_85fb5a1a-e0c6-4dc2-b3de-4cc0f6afa490.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
.ALPHA.-LIPOIC ACID	ACTIVE INGREDIENT	73Y7P0K73Y	1
ALCOHOL, X-RAY EXPOSED (1000 RAD)	ACTIVE INGREDIENT	6PRJ93602P	1
AVENA SATIVA FLOWERING TOP	ACTIVE INGREDIENT	MA9CQJ3F7F	1
BERBERIS VULGARIS ROOT BARK	ACTIVE INGREDIENT	1TH8Q20J0U	1
CAFFEINE	ACTIVE INGREDIENT	3G6A5W338E	1
CHOLESTEROL	ACTIVE INGREDIENT	97C5T2UQ7J	1
FRANGULA PURSHIANA BARK	ACTIVE INGREDIENT	4VBP01X99F	1
INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)	ACTIVE INGREDIENT	WC4E824FQ9	1
JUGLANS REGIA FLOWERING TOP	ACTIVE INGREDIENT	3BA2N709NG	1
KEROSENE	ACTIVE INGREDIENT	1C89KKC04E	1
RICINUS COMMUNIS SEED	ACTIVE INGREDIENT	7EK4SFN1TX	1
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE INGREDIENT	5405K23S50	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE INGREDIENT	269XH13919	1
TOBACCO LEAF	ACTIVE INGREDIENT	6YR2608RSU	1
URTICA URENS	ACTIVE INGREDIENT	IHN2NQ5OF9	1
VIOLA TRICOLOR	ACTIVE INGREDIENT	9Q24RAI43V	1
.ALPHA.-LIPOIC ACID	ACTIVE MOIETY	73Y7P0K73Y	1
ALCOHOL, X-RAY EXPOSED (1000 RAD)	ACTIVE MOIETY	6PRJ93602P	1
AVENA SATIVA FLOWERING TOP	ACTIVE MOIETY	MA9CQJ3F7F	1
BERBERIS VULGARIS ROOT BARK	ACTIVE MOIETY	1TH8Q20J0U	1
CAFFEINE	ACTIVE MOIETY	3G6A5W338E	1
CHOLESTEROL	ACTIVE MOIETY	97C5T2UQ7J	1
FRANGULA PURSHIANA BARK	ACTIVE MOIETY	4VBP01X99F	1
INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)	ACTIVE MOIETY	WC4E824FQ9	1
JUGLANS REGIA FLOWERING TOP	ACTIVE MOIETY	3BA2N709NG	1
KEROSENE	ACTIVE MOIETY	1C89KKC04E	1
RICINUS COMMUNIS SEED	ACTIVE MOIETY	7EK4SFN1TX	1
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE MOIETY	5405K23S50	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE MOIETY	269XH13919	1
TOBACCO LEAF	ACTIVE MOIETY	6YR2608RSU	1
URTICA URENS	ACTIVE MOIETY	IHN2NQ5OF9	1
VIOLA TRICOLOR	ACTIVE MOIETY	9Q24RAI43V	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

Body Pure
.ALPHA.-LIPOIC ACID and AVENA SATIVA FLOWERING TOP and RICINUS COMMUNIS SEED and SOLIDAGO VIRGAUREA FLOWERING TOP and VIOLA TRICOLOR and BERBERIS VULGARIS ROOT BARK and CAFFEINE and JUGLANS REGIA FLOWERING TOP and FRANGULA PURSHIANA BARK and URTICA URENS and CHOLESTEROL and INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED) and KEROSENE and TOBACCO LEAF and ALCOHOL, X-RAY EXPOSED (1000 RAD) and STRYCHNOS NUX-VOMICA SEED
.ALPHA.-LIPOIC ACID
AVENA SATIVA FLOWERING TOP
RICINUS COMMUNIS SEED
SOLIDAGO VIRGAUREA FLOWERING TOP
VIOLA TRICOLOR
BERBERIS VULGARIS ROOT BARK
CAFFEINE
JUGLANS REGIA FLOWERING TOP
FRANGULA PURSHIANA BARK
URTICA URENS
CHOLESTEROL
INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)
KEROSENE
TOBACCO LEAF
ALCOHOL, X-RAY EXPOSED (1000 RAD)
STRYCHNOS NUX-VOMICA SEED
LACTOSE
MAGNESIUM STEARATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50114-4426	50114-4426-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
.ALPHA.-LIPOIC ACID	73Y7P0K73Y	ACTIB
AVENA SATIVA FLOWERING TOP	MA9CQJ3F7F	ACTIB
RICINUS COMMUNIS SEED	7EK4SFN1TX	ACTIB
SOLIDAGO VIRGAUREA FLOWERING TOP	5405K23S50	ACTIB
VIOLA TRICOLOR	9Q24RAI43V	ACTIB
BERBERIS VULGARIS ROOT BARK	1TH8Q20J0U	ACTIB
CAFFEINE	3G6A5W338E	ACTIB
JUGLANS REGIA FLOWERING TOP	3BA2N709NG	ACTIB
FRANGULA PURSHIANA BARK	4VBP01X99F	ACTIB
URTICA URENS	IHN2NQ5OF9	ACTIB
CHOLESTEROL	97C5T2UQ7J	ACTIB
INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)	WC4E824FQ9	ACTIB
KEROSENE	1C89KKC04E	ACTIB
TOBACCO LEAF	6YR2608RSU	ACTIB
ALCOHOL, X-RAY EXPOSED (1000 RAD)	6PRJ93602P	ACTIB
STRYCHNOS NUX-VOMICA SEED	269XH13919	ACTIB
LACTOSE	J2B2A4N98G	IACT
MAGNESIUM STEARATE	70097M6I30	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 75 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE / ORAL		127 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TROCHE / ORAL		315 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SUSPENSION / ORAL		64 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE, FOR SUSPENSION / ORAL		14 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SYSTEM / INTRAVITREAL	0.02 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	WAFER / ORAL	66 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	GRANULE / ORAL		629 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / INTRAVITREAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INSERT / VAGINAL		69 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, EXTENDED RELEASE / ORAL		173 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / ORAL		25 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / RESPIRATORY (INHALATION)	0.13 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INHALANT / ORAL	0.08 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	DROPS / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, COATED / ORAL		184 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
01a0c80e-4016-4cf7-b543-392ab1e7e4a3			85fb5a1a-e0c6-4dc2-b3de-4cc0f6afa490	2012-05-29	Warnings	Exact identifier spl id: 01a0c80e-4016-4cf7-b543-392ab1e7e4a3 spl set id: 85fb5a1a-e0c6-4dc2-b3de-4cc0f6afa490

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.